SALARIUS PHARMACEUTICALS, INC. CONSOLIDATED BALANCE SHEETS December 31, 2024 2023 Assets Current assets: Cash and cash equivalents $ 2,434,528 $ 5,899,910 Prepaid expenses and other current assets ...

SALARIUS PHARMACEUTICALS, INC. CONSOLIDATED STATEMENTS OF OPERATIONS 12 Months Ended December 31, 2024 2023 Operating expenses: Research and development 770,027 7,173,747 General and administrative ...

10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever 60.4% of Aligos Therapeutics shares are held by institutional investors.

We've identified the following companies as similar to Aligos Therapeutics Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics ...

Plus Therapeutics shares are trading higher by 244% during Thursday's session. The company announced that the FDA accepted the name REYOBIQ for the company's lead asset. The ‘Trade of the Day ...

TwoStep Therapeutics, a biotechnology company developing innovative, first-in-class, multispecific targeted peptide conjugate therapies for solid tumors, is pleased to announce its debut public ...

The company will henceforth be known as Whitehawk Therapeutics, it announced Tuesday. Its stock ticker will be updated accordingly: As of Wednesday, it will trade as “WHWK” on the Nasdaq ...